Vera Imper - 05 Jun 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Reporting relationship
Director
Issuer ticker
CTKB
Reported as of
05 Jun 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
07 Jun 2024, 18:53:39 UTC
Prior SEC filing
16 Jun 2023
Next SEC filing
09 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Valerie Barnett, Attorney-in-Fact

Key filing fact

Vera Imper filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 07 Jun 2024.

Key facts

  • This page summarizes Vera Imper's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 07 Jun 2024, 18:53.

Change

  • Previous filing in this sequence was filed on 16 Jun 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTKB transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+15,706
Change %
Price
$0.000000
Shares after
15,706
Date
05 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,706
Exercise price
Footnotes
F1, F2
CTKB transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+23,076
Change %
Price
$0.000000
Shares after
23,076
Date
05 Jun 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
23,076
Exercise price
$5.73
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

100% of the shares subject to the RSU Award shall vest on June 5, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .